Sale of Labema to Indutrade
Indutrade has signed an agreement to acquire all shares in the Finnish company Labema Oy.
Located in Helsinki, Finland, Labema is a technical trading company operating within the life science and biotechnology field, offering diagnostic equipment and supplies primarily to public healthcare, food industry and research laboratories. The company has a strong sales-oriented culture with high technical expertise in microbiology, molecular biology, food diagnostics and biobanking robotics, among others. Founded in 1988, Labema has 20 employees and a revenue of approximately 6.3 million euros.
After the transaction’s closing on 14 June 2023, Labema will be included in Indutrade’s business area Finland. The acquisition is expected to have a marginally positive impact on Indutrade’s earnings per share.
Carner Corporate Finance advised the owners of Labema throughout the sale process.
Indutrade
Indutrade is an international technology and industrial business group that consists of approximately 200 companies in some 30 countries, mainly in Europe. Indutrade acquires and develops successful, well-managed and profitable companies. The group companies develop, manufacture, and sell components, systems and services in selected niches. Indutrade’s net sales totaled SEK 27 billion in 2022, and the group’s share is listed on Nasdaq Stockholm.